SCHEMBL6570435

SCHEMBL6570435

C[C@@H](NC(=O)Cc1c[nH]cn1)C(N)=O

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 5/20 0.34
SHMT1 P34896 3/20 0.34
HPGDS O60760 2/20 0.33
RECQL P46063 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA9 Q16790 1/20 0.30
S1PR1 P21453 1/20 0.30
VHL P40337 1/20 0.30
HRH1 P35367 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3009276 0.84 VHL (0.42) KDM4EALDH1A1SMN1; SMN2VHL
SCHEMBL3014470 0.81 KDM4E (0.42) KDM4EALDH1A1SMN1; SMN2HRH3
SCHEMBL30799829 0.79 GHSR (0.37)
SCHEMBL9238328 0.78 MBTPS1 (0.43) ALDH1A1SMN1; SMN2
SCHEMBL7676173 0.76 KMT2A (0.33)
SCHEMBL5880077 0.76 KDM6B (0.40) KDM4EALDH1A1
SCHEMBL7471241 0.75 CAPN1 (0.37)
SCHEMBL27496719 0.75 PSMB8 (0.32)
SCHEMBL10556873 0.75 DPP4 (0.33)
SCHEMBL9811844 0.75 CA12 (0.34) CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395551-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2002098849-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND SIMILAR DISEASES ELAN PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed